// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























1151 Abstracts

Effect of Treat-to-Target Tocilizumab- and Methotrexate-Based Strategies on Health-Related Quality of Life in Newly Diagnosed Rheumatoid Arthritis Patients: Results of the U-Act-Early Trial

Xavier M Teitsma - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Hydroxychloroquine in Lupus Pregnancy: A Meta-Analysis of Individual Participant Data

Amanda M. Eudy - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Hydroxychloroquine Initiation Dosing Trends and Predictors in Systemic Lupus Erythematosus

April Jorge - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Hydroxychloroquine Level Decreases throughout Pregnancy: Implications for Maternal and Neonatal Outcomes

Stephen Balevic - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Hydroxychloroquine Non-Adherence Is Associated with Higher Sledai Scores in a Predominantly Hispanic Population

Alexandra Perel-Winkler - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Hydroxychloroquine Use Is Associated with Decreased Dendritic Cell Activation and Thrombolytic Factors in SLE Patients

Samantha Slight-Webb - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Is Risk of Retinopathy Among Hydroxychloroquine Users of SLE Patients Accurate? a Simulation Study Accounting for Competing Risk of Death

Na Lu - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Hydroxychloroquine

Is There a Seasonal Effect on Fatigue, Pain, and Dryness in Primary Sjögren’s Syndrome?  Data from the Prospective Assess Cohort and  from 3 Randomized Controlled Trials

Pierre-Marie DURET - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Low Health Literacy Does Not Impact Adherence to Hydroxychloroquine in Patients with Systemic Lupus

Alexandra Perel-Winkler - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

New Guidelines on Hydroxychloroquine Dosage – Where Are We?

Shriyanka Jain - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Hydroxychloroquine

New Use for an Old Drug: Hydroxychloroquine for the Treatment of ANCA Associated Vasculitis

Alina Casian - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Osteopontin and Leptin Are Associated with Erosive Disease in an Inception Cohort of Rheumatoid Arthritis Treated-to-Target with Combination Conventional DMARD Therapy

Mihir D. Wechalekar - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Patient Education Materials in Rheumatology: Only Adequate at Best

Aleksander Lenert - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Predicting Remission at 6 Months in Early Rheumatoid Arthritis Treated with Conventional Synthetic Dmards

Michael D Wiese - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Preterm Delivery Phenotypes in SLE Pregnancies

Julia F Simard - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

N/A

Hydroxychloroquine

Prevalence of Blindness in a Cohort of Rheumatologic Patients Treated with Hydroxychloroquine

Dilpreet Singh - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Real World IGRA Testing in Rheumatology Practice

Paul DeMarco - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Safety of Hydroxychloroquine Withdrawal in Older Adults with Systemic Lupus Erythematosus

Anna Zezon - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Screening in Patients at High Risk of Hydroxychloroquine Retinal Toxicity

Anna Viola Taulaigo - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Switching from Synthetic to Biologic Dmards – Is There an Insufficient Use of Methotrexate?

Lisa Baganz - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Copyright © 2026. QuantiNova All rights reserved